Pain in Inflammatory Joint Diseases
Launched by DIAKONHJEMMET HOSPITAL · Dec 2, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to explore the causes and effects of chronic pain in patients with different types of inflammatory arthritis, including rheumatoid arthritis and psoriatic arthritis. Researchers want to learn more about how the brain and body respond to pain and how this can affect a patient’s overall health and treatment. They will be looking at various factors that may influence pain levels and how these factors relate to the progress of the disease over time.
If you are a patient who is starting or changing a specific type of medication for your arthritis, you may be eligible to participate in this study. There are no specific exclusions, so if you meet the inclusion criteria, you could join. Participants can expect to share their experiences and undergo assessments to help researchers understand the relationship between pain, disease activity, and treatment outcomes. This research is important as it aims to improve pain management and overall care for those living with inflammatory joint diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients who initiate or switch biological or targeted synthetic DMARDs
- Exclusion Criteria:
- • None
About Diakonhjemmet Hospital
Diakonhjemmet Hospital is a leading healthcare institution in Norway, dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the hospital fosters a research environment that prioritizes patient safety and ethical standards. Committed to translating scientific findings into clinical practice, Diakonhjemmet Hospital engages in a diverse range of studies across various medical fields, aiming to enhance treatment outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported